Market Research Logo

Biodesix Inc - Product Pipeline Analysis, 2018 Update

Summary

Biodesix Inc (Biodesix) is a molecular diagnostics company which discovers, develops and commercializes multivariate protein and genomic diagnostic blood tests in oncology for patients and doctors to enable precision medicine. These tests are used for early detection of diseases, diagnosis accuracy, disease monitoring and also provide improved therapeutic guidance for cancer patients. Biodesix’s product portfolio includes GeneStrat, a gene panel of clinically actionable mutations for tumor profiling for patients with advanced lung cancer; and VeriStrat, a serum proteomic test for patients with non-small cell lung cancer. The company collaborates with leading researchers to develop companion diagnostics for use with therapeutic agents and work in partnership with biotechnology and pharmaceutical companies such as Aveo Oncology and Biognosys. Biodesix is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biodesix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biodesix Inc Company Overview
Biodesix Inc Company Snapshot
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc – Pipeline Analysis Overview
Biodesix Inc - Key Facts
Biodesix Inc - Major Products and Services
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Pipeline Products Overview
GeneStrat
GeneStrat Product Overview
HRM-MS Based Companion Diagnostic Test
HRM-MS Based Companion Diagnostic Test Product Overview
PD-L1 Blood Based Diagnostic Test
PD-L1 Blood Based Diagnostic Test Product Overview
PD-L1 Blood Based Diagnostic Test Clinical Trial
TAm-Seq NGS Lung Cancer Test
TAm-Seq NGS Lung Cancer Test Product Overview
VeriStrat - Breast Cancer
VeriStrat - Breast Cancer Product Overview
VeriStrat - Colorectal Cancer
VeriStrat - Colorectal Cancer Product Overview
VeriStrat - NSCLC
VeriStrat - NSCLC Product Overview
VeriStrat - NSCLC Clinical Trial
Biodesix Inc - Key Competitors
Biodesix Inc - Key Employees
Biodesix Inc - Locations And Subsidiaries
Head Office
Recent Developments
Biodesix Inc, Recent Developments
Apr 30, 2018: New Data Demonstrate the Biodesix VeriStrat Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
Apr 18, 2018: New Data Shows Biodesix Blood Test Reliably Detects Additional Mutations in Patients with NSCLC
Apr 05, 2018: Biodesix Announces Data To Be Presented at AACR Annual Meeting 2018
Dec 20, 2017: Data Published In AACR Journal Suggest Biodesix Test in Development May Identify Melanoma Patients Who Could Benefit from Checkpoint Inhibitors
Dec 05, 2017: Biodesix Leaders Share Commercial and Pipeline Updates at Annual qPCR and dPCR Congress
Nov 16, 2017: Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStratTest
Nov 01, 2017: Biodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with Immunohistochemistry
Oct 25, 2017: Biodesix To Present Data at SITC Annual Meeting
Oct 06, 2017: 2018 Preliminary Private Payor Rate-Based Payment Amounts Released for Clinical Diagnostic Laboratory Tests; Biodesix Commends CMS for Committing to On-Time PAMA Implementation
Sep 20, 2017: Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat Proteomic Test
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Biodesix Inc Pipeline Products and Ongoing Clinical Trials Overview
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Indication
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc, Key Facts
Biodesix Inc, Major Products and Services
Biodesix Inc Number of Pipeline Products by Development Stage
Biodesix Inc Pipeline Products Summary by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status
Biodesix Inc Ongoing Clinical Trials Summary
GeneStrat - Product Status
GeneStrat - Product Description
HRM-MS Based Companion Diagnostic Test - Product Status
HRM-MS Based Companion Diagnostic Test - Product Description
PD-L1 Blood Based Diagnostic Test - Product Status
PD-L1 Blood Based Diagnostic Test - Product Description
PD-L1 Blood Based Diagnostic Test - Concordance of Immunohistochemistry and a New Blood-based Expression Assay for the Detection of PD-L1 in Patients Diagnosed with Non-small Cell Lung Cancer
TAm-Seq NGS Lung Cancer Test - Product Status
TAm-Seq NGS Lung Cancer Test - Product Description
VeriStrat - Breast Cancer - Product Status
VeriStrat - Breast Cancer - Product Description
VeriStrat - Colorectal Cancer - Product Status
VeriStrat - Colorectal Cancer - Product Description
VeriStrat - NSCLC - Product Status
VeriStrat - NSCLC - Product Description
VeriStrat - NSCLC - An Observational Study Assessing the Clinical Effectiveness of VeriStrat and Validating Immunotherapy Tests in Subjects with Non-small Cell Lung Cancer
Biodesix Inc, Key Employees
Glossary
List of Figures
Biodesix Inc Pipeline Products by Equipment Type
Biodesix Inc Pipeline Products by Development Stage
Biodesix Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report